AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibaglim M 3mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Kasdap Healthcare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (850mg)

Overview Dibaglim M 3mg/850mg Tablet

Metformin/glimepiride 3mg/850mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This combination helps regulate blood glucose in diabetic patients. These tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; premature discontinuation without medical consultation can elevate blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms – sweating, dizziness, headache, tremors – and how to address them. Regular meals and carrying a rapid-acting glucose source (e.g., sugary foods, juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to track blood cell counts and liver function, are recommended by your doctor.

Uses of Dibaglim M 3mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Dibaglim M 3mg/850mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; do not chew, crush, or fracture it. The Dibaglim M 3mg/850mg Tablet should be administered with a meal.

Common Side effects of Dibaglim M 3mg/850mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibaglim M 3mg/850mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dibaglim M 3mg/850mg tablets with a meal.

How Dibaglim M 3mg/850mg Tablet works:

Dibaglim M 3mg/850mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Dibaglim M 3mg/850mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dibaglim M 3mg/850mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The medication Dibaglim M 3mg/850mg tablets should not be taken while breastfeeding. Evidence indicates a potential for infant harm due to the drug's toxicity.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dibaglim M 3mg/850mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Dibaglim M 3mg/850mg tablets. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Dibaglim M 3mg/850mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiation with a reduced Dibaglim M 3mg/850mg tablet dosage is typical; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Dibaglim M 3mg/850mg Tablet :

Should you forget a Dibaglim M 3mg/850mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibaglim M 3mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dibaglim M 3mg/850mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Dibaglim M 3mg/850mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Dibaglim M 3mg/850mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Dibaglim M 3mg/850mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Dibaglim M 3mg/850mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Dibaglim M 3mg/850mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol while taking Dibaglim M 3mg/850mg tablets is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Dibaglim M 3mg/850mg Tabl...
90
MRP 110
18% off